Macquarie Group LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $2,389 - $4,804	-2,542 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$4.79 - $8.39 $12,176 - $21,327	2,542 New	2,542 $21,000
Q1 2018 May 11, 2018	SELL	$5.6 - $9.25 $6,720 - $11,100	-1,200 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$6.6 - $7.78 $7,920 - $9,336	1,200	1,200 $9,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.26B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.